The EMPA-KIDNEY Study: A Multicentre International Randomized Parallel Group Double-Blind Placebo-Controlled Clinical Trial of EMPAgliflozin Once Daily to Assess Cardio-Renal Outcomes in Patients with Chronic KIDNEY Disease

Project Details

StatusNot started